Inflammatory Bowel Disease Research Review, Issue 91

In this issue:

Adding appendicectomy to standard medical therapy for maintaining UC remission
1-year of guselkumab vs. advanced therapies for moderate-to-severe CD
Long-term outcomes after TNF inhibitor withdrawal in IBD in remission
Biologics within 12 months of CD diagnosis: greater transmural healing
Epidemiology of elderly-onset IBD
Role of prediagnosis environmental factors on IBD activity and severity
Etrasimod with concomitant opioids/antidepressants in UC
Rectal tacrolimus in UC
Efficacy of biologics and small molecules in maintenance UC therapy
Vedolizumab in patients aged ≥70 vs. <70 years with UC

Please login below to download this issue (PDF)

Subscribe